ducovest

ZHU:CA:TSX-BMO Equal Weight US Health Care Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 39.52

Change

+0.07 (+0.18)%

Market Cap

CAD 0.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-29 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

N/A

 CAD 3.27B
ZWU:CA BMO Covered Call Utilities ETF

N/A

 CAD 1.83B
XIT:CA iShares S&P/TSX Capped Informa..

N/A

 CAD 0.72B
HTA:CA Harvest Tech Achievers Growth ..

N/A

 CAD 0.59B
ZUT:CA BMO Equal Weight Utilities Ind..

N/A

 CAD 0.57B
TXF:CA First Asset Tech Giants Covere..

N/A

 CAD 0.57B
XHC:CA iShares Global Healthcare (CAD..

N/A

 CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

N/A

 CAD 0.35B
CWW:CA iShares Global Water Common Cl..

N/A

 CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

N/A

 CAD 0.29B

ETFs Containing ZHU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.41% 11% F 13% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.41% 11% F 12% F
Trailing 12 Months  
Capital Gain -5.30% 29% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.30% 20% F 16% F
Trailing 5 Years  
Capital Gain 6.24% 29% F 35% F
Dividend Return 2.12% 15% F 3% F
Total Return 8.36% 14% F 23% F
Average Annual (5 Year Horizon)  
Capital Gain 2.76% 40% F 45% F
Dividend Return 2.79% 23% F 37% F
Total Return 0.03% 6% D- 2% F
Risk Return Profile  
Volatility (Standard Deviation) 10.27% 80% B- 71% C-
Risk Adjusted Return 27.21% 23% F 42% F
Market Capitalization 0.01B 12% F 10% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.